Clinical trial · Observational
Prospective Study for Prognostic Biomarkers of Nasopharyngeal Carcinoma
NCT03025854CI-TRIAL-00047630unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this clinical research project is to explore potential biomarkers and validate the predictive and prognostic value of molecular signature in nasopharyngeal carcinoma.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Nasopharyngeal Carcinoma | Nasopharyngeal Carcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Failure-free Survival
- timeFrame
- 3 years
Secondary outcomes (1)
- measure
- Overall Survival
- timeFrame
- 3 years
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * Patients with newly histologically confirmed nasopharyngeal carcinoma * No evidence of distant metastasis (M0) * Written informed consent Exclusion Criteria: * Treatment with palliative intent
References
Publications (0)
Data not yet available
No reference posted for this study.